Get every channel available on your satellite radio, plus listen to SiriusXM online and on the app.* Itâs the only package that gives you all of our premium programming, including Howard Stern, every NFL, MLBÂ®, NBA and NHLÂ® game, every NASCARÂ® race, 24/7 talk channels dedicated to the biggest leagues and more.
As well, Cempra could well be a buyout target after Solithera is approved by the FDA. As recently as October 1, Cempra's share price was around $26. On October 27th, at the close of trading, Cempra released its Q3 earnings; it held its earnings conference calls that afternoon and filed its 10-Q report.
(TMFTypeoh). Jul 30, 2015 at 5:17PM. What: Shares of Genocea Biosciences (NASDAQ:GNCA), a biotech company with a focus on vaccines and immunotherapies, fell more than 10% today before moderating back to a 7% loss after the company announced the pricing of its recently announced $50 million public offering.o What: Genocea is selling 3.85 million shares of its common stock at a price of $13 per share, plus it is granting its underwriters the option to purchase an additional 577,500 shares at the same price.